ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

(HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival t

Updated on: March 30,2024

ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

(HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival t

Updated on:March 30,2024

Technique that characterizes different immune cell groups in individual patients could revolutionize cancer treatments

by Agency for Science, Technology and Research (A*STAR), SingaporeA plot of all the different possible phenotypes of T cells before without (left) vs. with (right) immune checkpoint blockade immu

Updated on: March 01,2024

Technique that characterizes different immune cell groups in individual patients could revolutionize cancer treatments

by Agency for Science, Technology and Research (A*STAR), SingaporeA plot of all the different possible phenotypes of T cells before without (left) vs. with (right) immune checkpoint blockade immu

Updated on:March 01,2024

Predicting efficacy of neoadjuvant chemotherapy for advanced gastric cancer

by Zhang Nannan,Chinese Academy of SciencesProcess for predicting the NACT efficacy in AGC. Credit: SIBETGastric cancer is a common malignant tumor that originates from the gastric mucosal epith

Updated on: February 24,2024

Predicting efficacy of neoadjuvant chemotherapy for advanced gastric cancer

by Zhang Nannan,Chinese Academy of SciencesProcess for predicting the NACT efficacy in AGC. Credit: SIBETGastric cancer is a common malignant tumor that originates from the gastric mucosal epith

Updated on:February 24,2024

Study: ChemoID platform-predicted treatments lead to longer survival for glioblastoma patients

by Tim Tedeschi,University of CincinnatiGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101025New multi-institutional phase 3 clinical trial data pub

Updated on: February 01,2024

Study: ChemoID platform-predicted treatments lead to longer survival for glioblastoma patients

by Tim Tedeschi,University of CincinnatiGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101025New multi-institutional phase 3 clinical trial data pub

Updated on:February 01,2024

Use of MMR deficiency testing in younger CRC patients is low

(HealthDay)—Fewer than half of younger adults with colorectal cancer (CRC) undergo mismatch repair (MMR) deficiency of DNA testing, according to a study published online Nov. 9 inJAMA Oncology.T

Updated on: April 22,2024

Use of MMR deficiency testing in younger CRC patients is low

(HealthDay)—Fewer than half of younger adults with colorectal cancer (CRC) undergo mismatch repair (MMR) deficiency of DNA testing, according to a study published online Nov. 9 inJAMA Oncology.T

Updated on:April 22,2024

Researchers are building detailed maps of colorectal cancer to better understand the dynamics of the disease

by Harvard Medical SchoolA 3D reconstruction of colorectal cancer revealed that what was once thought to be 2D mucin pools with clusters of cancer cells floating inside is actually a complex and

Updated on: February 24,2024

Researchers are building detailed maps of colorectal cancer to better understand the dynamics of the disease

by Harvard Medical SchoolA 3D reconstruction of colorectal cancer revealed that what was once thought to be 2D mucin pools with clusters of cancer cells floating inside is actually a complex and

Updated on:February 24,2024

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee

Updated on: March 30,2024

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee

Updated on:March 30,2024

New study finds disparities caused by algorithm in health care systems

by Drew Wiseman, Huntsman Cancer InstituteCredit: CC0 Public DomainPatients from historically medically underserved groups, including patients of color and those who are Spanish-speaking, have less ca

Updated on: February 01,2024

New study finds disparities caused by algorithm in health care systems

by Drew Wiseman, Huntsman Cancer InstituteCredit: CC0 Public DomainPatients from historically medically underserved groups, including patients of color and those who are Spanish-speaking, have less ca

Updated on:February 01,2024

Cis-regulatory sequences indicative of nasopharyngeal carcinoma risk identified

by Justin Jackson , Medical XpressCredit:The American Journal of Human Genetics(2023). DOI: 10.1016/j.ajhg.2023.06.003Research led by the Sun Yat-sen University Cancer Center in China has

Updated on: February 01,2024

Cis-regulatory sequences indicative of nasopharyngeal carcinoma risk identified

by Justin Jackson , Medical XpressCredit:The American Journal of Human Genetics(2023). DOI: 10.1016/j.ajhg.2023.06.003Research led by the Sun Yat-sen University Cancer Center in China has

Updated on:February 01,2024

Mailing colorectal cancer screening kit found effective, regardless of financial incentive

by Perelman School of Medicine at the University of PennsylvaniaCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer is the second deadliest cancer i

Updated on: May 09,2024

Mailing colorectal cancer screening kit found effective, regardless of financial incentive

by Perelman School of Medicine at the University of PennsylvaniaCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer is the second deadliest cancer i

Updated on:May 09,2024

Potential therapeutic target for small cell lung cancer discovered

by Melissa Rohman,Northwestern UniversityGraphic model showing how POU2AF2 establishes the poised enhancer via SWI/SNF activity-dependent recruitment of the Polycomb complex in SCLC-P subtype ce

Updated on: April 28,2024

Potential therapeutic target for small cell lung cancer discovered

by Melissa Rohman,Northwestern UniversityGraphic model showing how POU2AF2 establishes the poised enhancer via SWI/SNF activity-dependent recruitment of the Polycomb complex in SCLC-P subtype ce

Updated on:April 28,2024

Maternal obesity may promote liver cancer

by University of GenevaCredit:JHEP Reports(2024). DOI: 10.1016/j.jhepr.2024.101056Obesity, which could reach 50% of the population in certain developed countries by 2030, is a major p

Updated on: March 20,2024

Maternal obesity may promote liver cancer

by University of GenevaCredit:JHEP Reports(2024). DOI: 10.1016/j.jhepr.2024.101056Obesity, which could reach 50% of the population in certain developed countries by 2030, is a major p

Updated on:March 20,2024